CJC-1295 DAC

Description

CJC-1295 DAC

CJC-1295 DAC is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), engineered for prolonged activity to promote sustained increases in natural growth hormone and IGF-1 levels. Compared to the non-DAC variant, it includes a Drug Affinity Complex (DAC) that greatly prolongs its half-life, enabling less frequent administration. This extended release supports research into improved recovery, preservation of lean muscle, fat metabolism, better sleep quality, and anti-aging effects. It is commonly incorporated into body composition and wellness regimens where sustained growth hormone stimulation and enhanced recovery are desired.

Also known as: Modified GRF 1-29 DAC, Drug Affinity Complex CJC

• Status: Currently investigational – classified as a research compound. Evidence level: Studies conducted in humans.
• Typical administration: Dosing information is sparse within public sources (refer to established research protocols); delivered via subcutaneous injection.
• Primary research focus: Prolonged growth hormone (GH) elevation, enhancement of muscle mass, and improved recovery.